Procarbazine (Matulane (US), Natulan (Canada), Indicarb (India))'s an antineoplastic chemotherapy drug for the treatment of Hodgkin's lymphoma and certain brain cancers (such as Glioblastoma multiforme). It's a member of a group of medicines called alkylating agents. It gained FDA Approved in July 1969. The drug's metabolized and activated in the liver. It also inhibits MAO thus increasing the effects of sympathomimetics, TCAs, and tyramine. Pharmacology Its mechanism of action isn't fully unde… (More on Procarbazine)